Company / CapEx per Share
Cytek Biosciences, Inc. CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.03
FY2025
5-year range
$0.03 / $0.07
FY2021-FY2025
Trend
+16.4%
vs FY2024
Sector context
#136 of 148
Health Care
What the data says
Among 148 Health Care companies, Cytek Biosciences, Inc. is in the bottom 8% for capex per share. CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.03.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -7.7%.
Declined from $0.04 to $0.03 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -24.2%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 148This company $0.03 Sector average $1.67
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 16.4% year-over-year.
- Ranks #136 out of 148 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +16.4% |
| FY2024 | $0.03 | -23.3% |
| FY2023 | $0.04 | -51.2% |
| FY2022 | $0.07 | +47.2% |
| FY2021 | $0.05 | +4.3% |
| FY2020 | $0.05 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026